4 results
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Heparin, Fondaparinux ... and Novel Oral Anticoagulants ... #UFH #DOAC #Dabigatran ... #Apixaban #Rivaroxaban ... NOAC #Mechanism
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Anticoagulants Common ... PCC (Kcentra) - Heparin ... #doac #noac #pharmacology ... #hematology #reversal ... #toxicology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
oral anticoagulants ... filtration rate; DOAC ... oral anticoagulant ... #DOAC #VTE #Malignancy ... #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
consider withholding anticoagulant ... DOAC, direct oral ... anticoagulant; ... #DOAC #VTE #Malignancy ... #Management #Hematology